{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:50:02Z","timestamp":1774511402777,"version":"3.50.1"},"reference-count":109,"publisher":"MDPI AG","issue":"13","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Hepatocellular carcinoma (HCC) is a frequent complication of various liver diseases, occurring with or without underlying cirrhosis. While cirrhosis and chronic liver inflammation are well-established major drivers of hepatocarcinogenesis, HCC can also develop in patients with vascular liver diseases (VLDs), highlighting an alternative pathway of disease progression. Alterations in liver perfusion appear to underlie the process of carcinogenesis. However, the specific molecular mechanisms involved in this process as well as the clinical presentation and imaging features of HCC in the most common VLDs are still a matter of debate. This review aims to evaluate the available literature on the topic to provide a deeper comprehension and analysis of current knowledge about the relation between VLDs and HCC. Specifically, we investigate how HCC affects VLDs such as Budd\u2013Chiari syndrome, Fontan-associated liver disease, congenital portosystemic shunts, cavernous transformation of the portal vein, and porto-sinusoidal vascular disorder. Exploring the pathogenetic mechanisms and diagnostic challenges in HCC related to VLDs may have important therapeutic implications, helping to define targeted treatments for this poorly understood medical entity.<\/jats:p>","DOI":"10.3390\/cancers17132060","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T05:17:42Z","timestamp":1750396662000},"page":"2060","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Role of Vascular Liver Diseases in Hepatocellular Carcinoma Development"],"prefix":"10.3390","volume":"17","author":[{"given":"Lucia","family":"Giuli","sequence":"first","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeria","family":"De Gaetano","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Venturini","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ersilia","family":"Arvonio","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5578-0854","authenticated-orcid":false,"given":"Marco","family":"Murgiano","sequence":"additional","affiliation":[{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Universita\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6230-1779","authenticated-orcid":false,"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Universita\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Santopaolo","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5924-6238","authenticated-orcid":false,"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[{"name":"Liver Unit, Centro Malattie dell\u2019Apparato Digerente (CEMAD), Medicina Interna e Gastroenterologia, Fondazione Policlinico Universitario Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00168 Rome, Italy"},{"name":"Dipartimento di Medicina e Chirurgia Traslazionale, Universita\u00e0 Cattolica del Sacro Cuore, 00168 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,6,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL Clinical Practice Guidelines on the Management of Hepatocellular Carcinoma","volume":"82","author":"Sangro","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2147\/JHC.S61146","article-title":"Hepatocellular Carcinoma: A Review","volume":"3","author":"Balogh","year":"2016","journal-title":"J. Hepatocell. Carcinoma"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1007\/s00261-018-1502-7","article-title":"Benign and Malignant Hepatocellular Lesions in Patients with Vascular Liver Diseases","volume":"43","author":"Vilgrain","year":"2018","journal-title":"Abdom. Radiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00428-018-2373-6","article-title":"Hepatocellular Nodules in Vascular Liver Diseases","volume":"473","author":"Sempoux","year":"2018","journal-title":"Virchows Arch."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/cld.338","article-title":"Benign and Malignant Hepatocellular Lesions in Patients with Vascular Liver Disease: Hepatocellular Lesions in Vascular Liver Disease","volume":"3","author":"Vilgrain","year":"2014","journal-title":"Clin. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Valla, D., Garcia-Pagan, J.C., De Gottardi, A., and Rautou, P.-E. (2022). Vascular Disorders of the Liver: VALDIG\u2019s Guide to Management and Causes, Springer International Publishing.","DOI":"10.1007\/978-3-030-82988-9"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"(2016). EASL Clinical Practice Guidelines: Vascular Diseases of the Liver. J. Hepatol., 64, 179\u2013202.","DOI":"10.1016\/j.jhep.2015.07.040"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12072-017-9810-5","article-title":"Budd\u2013Chiari Syndrome\/Hepatic Venous Outflow Tract Obstruction","volume":"12","author":"Valla","year":"2018","journal-title":"Hepatol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/kjm2.12368","article-title":"Epidemiology, Pathogenesis, Diagnosis, Surveillance, and Management of Hepatocellular Carcinoma Associated with Vascular Liver Disease","volume":"37","author":"Prasad","year":"2021","journal-title":"Kaohsiung J. Med. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.diii.2021.09.001","article-title":"MR Imaging Features and Long-Term Evolution of Benign Focal Liver Lesions in Budd-Chiari Syndrome and Fontan-Associated Liver Disease","volume":"103","author":"Panvini","year":"2022","journal-title":"Diagn. Interv. Imaging"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/hep.510270224","article-title":"Pathology of the Liver in Budd-Chiari Syndrome: Portal Vein Thrombosis and the Histogenesis of Veno-Centric Cirrhosis, Veno-Portal Cirrhosis, and Large Regenerative Nodules","volume":"27","author":"Tanaka","year":"1998","journal-title":"Hepatology"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Rizzetto, F., Rutanni, D., Carbonaro, L.A., and Vanzulli, A. (2023). Focal Liver Lesions in Budd-Chiari Syndrome: Spectrum of Imaging Findings. Diagnostics, 13.","DOI":"10.3390\/diagnostics13142346"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/apt.13173","article-title":"Incidence and Risk Factors of Hepatocellular Carcinoma in Patients with Hepatic Venous Outflow Tract Obstruction","volume":"41","author":"Paul","year":"2015","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.dld.2025.02.008","article-title":"Clinical Characteristics and Risk Factors of Hepatocellular Carcinoma Development in Budd-Chiari Syndrome Patients after Endovascular Treatment","volume":"57","author":"Huang","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1016\/j.cgh.2022.08.042","article-title":"Minimal Risk of Hepatocellular Carcinoma in Noncirrhotic Budd-Chiari Syndrome: A Three-Decade Population-Based Study","volume":"21","author":"Wester","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Li, K.-S., Guo, S., Chen, Y.-X., and Zhang, Z.-L. (2022). Budd-Chiari Syndrome and Its Associated Hepatocellular Carcinoma: Clinical Risk Factors and Potential Immunotherapeutic Benefit Analysis. Front. Oncol., 12.","DOI":"10.3389\/fonc.2022.1075685"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4251\/wjgo.v16.i3.699","article-title":"Clinical Profile and Outcomes of Hepatocellular Carcinoma in Primary Budd-Chiari Syndrome","volume":"16","author":"Agarwal","year":"2024","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/gut.2007.139477","article-title":"Hepatocellular Carcinoma in Budd-Chiari Syndrome: Characteristics and Risk Factors","volume":"57","author":"Moucari","year":"2008","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.3748\/wjg.v18.i16.1946","article-title":"Hepatocellular Carcinoma in Budd-Chiari Syndrome: A Single Center Experience with Long-Term Follow-up in South Korea","volume":"18","author":"Park","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.27387","article-title":"Chronic Passive Venous Congestion Drives Hepatic Fibrogenesis via Sinusoidal Thrombosis and Mechanical Forces","volume":"61","author":"Simonetto","year":"2015","journal-title":"Hepatology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1053\/jhep.2003.50076","article-title":"Arterial and Portal Circulation and Parenchymal Changes in Budd\u2013Chiari Syndrome: A Study in 17 Explanted Livers","volume":"37","author":"Vilgrain","year":"2003","journal-title":"Hepatology"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.3760\/cma.j.issn.0366-6999.20130898","article-title":"Clinical and Pathological Features and Surgical Treatment of Budd-Chiari Syndrome-Associated Hepatocellular Carcinoma","volume":"126","author":"Wang","year":"2013","journal-title":"Chin. Med. J. (Engl.)"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00042737-200403000-00012","article-title":"Characteristic Clinical Features of Hepatocellular Carcinoma Associated with Budd???Chiari Syndrome: Evidence of Different Carcinogenic Process from Hepatitis B Virus-Associated Hepatocellular Carcinoma","volume":"16","author":"Shin","year":"2004","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1007\/s00261-018-1744-4","article-title":"White Paper of the Society of Abdominal Radiology Hepatocellular Carcinoma Diagnosis Disease-Focused Panel on LI-RADS V2018 for CT and MRI","volume":"43","author":"Elsayes","year":"2018","journal-title":"Abdom. Radiol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jjcc.2019.02.016","article-title":"Fontan-Associated Liver Disease: A Review","volume":"74","author":"Bove","year":"2019","journal-title":"J. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/CLD.0000000000000061","article-title":"Fontan-Associated Liver Disease","volume":"22","author":"Hilscher","year":"2023","journal-title":"Clin. Liver Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/hrt.2006.094516","article-title":"Hepatic Changes in the Failing Fontan Circulation","volume":"93","author":"Kiesewetter","year":"2007","journal-title":"Heart"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.amjcard.2016.02.042","article-title":"Exercise-Induced Systemic Venous Hypertension in the Fontan Circulation","volume":"117","author":"Navaratnam","year":"2016","journal-title":"Am. J. Cardiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MOG.0000000000000355","article-title":"Current Concepts in Ischemic Hepatitis","volume":"33","author":"Lightsey","year":"2017","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0002-9343(00)00461-7","article-title":"Ischemic Hepatitis: Clinical Presentation and Pathogenesis","volume":"109","author":"Seeto","year":"2000","journal-title":"Am. J. Med."},{"key":"ref_31","first-page":"1232","article-title":"Role of Thrombosis in the Pathogenesis of Congestive Hepatic Fibrosis (Cardiac Cirrhosis)","volume":"21","author":"Wanless","year":"1995","journal-title":"Hepatology"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/hep.20054","article-title":"PAR1 Antagonism Protects against Experimental Liver Fibrosis. Role of Proteinase Receptors in Stellate Cell Activation","volume":"39","author":"Fiorucci","year":"2004","journal-title":"Hepatology"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Airola, C., Pallozzi, M., Cerrito, L., Santopaolo, F., Stella, L., Gasbarrini, A., and Ponziani, F.R. (2023). Microvascular Thrombosis and Liver Fibrosis Progression: Mechanisms and Clinical Applications. Cells, 12.","DOI":"10.3390\/cells12131712"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00247-012-2531-y","article-title":"Hepatic Pathology after Fontan Palliation: Spectrum of Imaging Findings","volume":"43","author":"Wallihan","year":"2013","journal-title":"Pediatr. Radiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ijcard.2010.05.047","article-title":"Arterialised Hepatic Nodules in the Fontan Circulation: Hepatico-Cardiac Interactions","volume":"151","author":"Bryant","year":"2011","journal-title":"Int. J. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1148\/radiographics.22.4.g02jl17847","article-title":"Benign Regenerative Nodules in Budd-Chiari Syndrome and Other Vascular Disorders of the Liver: Radiologic-Pathologic and Clinical Correlation","volume":"22","author":"Brancatelli","year":"2002","journal-title":"RadioGraphics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.jhep.2023.07.013","article-title":"EASL-ERN Position Paper on Liver Involvement in Patients with Fontan-Type Circulation","volume":"79","author":"Tjwa","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/hepr.13500","article-title":"Characteristics of Hepatocellular Carcinoma Arising from Fontan-associated Liver Disease","volume":"50","author":"Sagawa","year":"2020","journal-title":"Hepatol. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.xjtc.2020.03.008","article-title":"Prevalence of Hepatocellular Carcinoma in the Entire Fontan Population of Australia and New Zealand","volume":"2","author":"Wilson","year":"2020","journal-title":"JTCVS Tech."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1007\/s10620-024-08470-1","article-title":"A Meta-Analysis of Cumulative Incidence of Hepatocellular Carcinoma After the Fontan Operation","volume":"69","author":"Hansen","year":"2024","journal-title":"Dig. Dis. Sci."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jtcvs.2004.10.005","article-title":"Progression of Liver Pathology in Patients Undergoing the Fontan Procedure: Chronic Passive Congestion, Cardiac Cirrhosis, Hepatic Adenoma, and Hepatocellular Carcinoma","volume":"129","author":"Ghaferi","year":"2005","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Yoon, J.S., Lee, D.H., Cho, E.J., Song, M.K., Choi, Y.H., Kim, G.B., Lee, Y.B., Lee, J.-H., Yu, S.J., and Kim, H. (2020). Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance. Cancers, 12.","DOI":"10.3390\/cancers12071805"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/hepr.13582","article-title":"Hepatocellular Carcinoma after Fontan Surgery: A Systematic Review","volume":"51","author":"Guerrero","year":"2021","journal-title":"Hepatol. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"79","DOI":"10.14218\/JCTH.2017.00067","article-title":"Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review","volume":"6","author":"Axley","year":"2018","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/heartjnl-2022-320940","article-title":"Predictors of Liver Cirrhosis and Hepatocellular Carcinoma among Perioperative Survivors of the Fontan Operation","volume":"109","author":"Inuzuka","year":"2023","journal-title":"Heart"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s00535-021-01842-8","article-title":"The Absence of Warfarin Treatment and Situs Inversus Are Associated with the Occurrence of Hepatocellular Carcinoma after Fontan Surgery","volume":"57","author":"Sakamori","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13244-018-0609-2","article-title":"Abdominal Imaging Findings in Adult Patients with Fontan Circulation","volume":"9","author":"Kim","year":"2018","journal-title":"Insights Imaging"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s00261-011-9686-0","article-title":"Hepatocellular Nodules in Liver Cirrhosis: Contrast-Enhanced Ultrasound","volume":"36","author":"Kim","year":"2011","journal-title":"Abdom. Imaging"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.3748\/wjg.v20.i13.3590","article-title":"Contrast-Enhanced Ultrasound in the Diagnosis of Nodules in Liver Cirrhosis","volume":"20","author":"Kim","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1007\/s00261-021-02994-0","article-title":"Spectrum of Fontan-Associated Liver Disease Assessed by MRI and US in Young Adolescents","volume":"46","author":"Thrane","year":"2021","journal-title":"Abdom. Radiol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00247-020-04776-0","article-title":"Imaging of Fontan-Associated Liver Disease","volume":"50","author":"Dillman","year":"2020","journal-title":"Pediatr. Radiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.hlc.2019.09.010","article-title":"Management of People With a Fontan Circulation: A Cardiac Society of Australia and New Zealand Position Statement","volume":"29","author":"Zentner","year":"2020","journal-title":"Heart Lung Circ."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijcard.2020.08.057","article-title":"Hepatocellular Carcinoma and the Fontan Circulation: Clinical Presentation and Outcomes","volume":"322","author":"Possner","year":"2021","journal-title":"Int. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1499-3872(15)60418-0","article-title":"Congenital Extrahepatic Portosystemic Shunt Complicated by the Development of Hepatocellular Carcinoma","volume":"14","author":"Sharma","year":"2015","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00431-017-3058-x","article-title":"Congenital Portosystemic Venous Shunt","volume":"177","author":"Papamichail","year":"2018","journal-title":"Eur. J. Pediatr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"100933","DOI":"10.1016\/j.jhepr.2023.100933","article-title":"Expert Management of Congenital Portosystemic Shunts and Their Complications","volume":"6","author":"McLin","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1097\/MPG.0b013e31828b3750","article-title":"Congenital Portosystemic Shunt: Characterization of a Multisystem Disease","volume":"56","author":"Sokollik","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MPG.0b013e3181d9cb92","article-title":"Complications of Congenital Portosystemic Shunts in Children: Therapeutic Options and Outcomes","volume":"51","author":"Branchereau","year":"2010","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.jpedsurg.2019.05.027","article-title":"Portal Venous Deprivation in Patients with Portosystemic Shunts and Its Effect on Liver Tumors","volume":"55","author":"Tyraskis","year":"2020","journal-title":"J. Pediatr. Surg."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1007\/s12072-022-10328-5","article-title":"Complications of Congenital Portosystemic Shunts: Liver Tumors Are Affected by Shunt Severity, but Pulmonary and Neurocognitive Associations Are Not","volume":"16","author":"Tyraskis","year":"2022","journal-title":"Hepatol. Int."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/MPG.0000000000001012","article-title":"Hepatoblastoma in Children With Congenital Portosystemic Shunts","volume":"62","author":"Lautz","year":"2016","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1055\/s-2007-965448","article-title":"Hepatoblastoma with Congenital Absence of the Portal Vein\u2014A Case Report","volume":"17","author":"Kawano","year":"2007","journal-title":"Eur. J. Pediatr. Surg."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/jhbp.277","article-title":"Hepatocellular Nodules Resulting from Congenital Extrahepatic Portosystemic Shunts Can Differentiate into Potentially Malignant Hepatocellular Adenomas","volume":"22","author":"Sanada","year":"2015","journal-title":"J. Hepato-Biliary-Pancreat. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1007\/s003300100833","article-title":"Congenital Absence of the Intrahepatic Portion of the Portal Vein in an Adult Male Resected for Hepatocellular Carcinoma","volume":"11","author":"Lundstedt","year":"2001","journal-title":"Eur. Radiol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e362","DOI":"10.1016\/j.crad.2013.01.024","article-title":"Congenital Portosystemic Shunts Associated with Liver Tumours","volume":"68","author":"Pupulim","year":"2013","journal-title":"Clin. Radiol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s003300051012","article-title":"Congenital Absence of Portal Vein with Nodular Regenerative Hyperplasia of the Liver","volume":"10","author":"Grazioli","year":"2000","journal-title":"Eur. Radiol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s005340070044","article-title":"Recent Developments in Imaging Diagnostics for HCC: CT Arteriography and CT Arterioportography Evaluation of Vascular Changes in Premalignant and Malignant Hepatic Nodules","volume":"7","author":"Honda","year":"2000","journal-title":"J. Hepatobiliary. Pancreat. Surg."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/j.1432-2277.2012.01454.x","article-title":"Focal Nodular Hyperplasia Proceeds Hepatocellular Carcinoma in an Adult with Congenital Absence of the Portal Vein: Letter to the Editors","volume":"25","author":"Scheuermann","year":"2012","journal-title":"Transpl. Int."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/hep.28638","article-title":"Genotype-phenotype Correlation of CTNNB1 Mutations Reveals Different SS-catenin Activity Associated with Liver Tumor Progression","volume":"64","author":"Rebouissou","year":"2016","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.clinre.2020.03.015","article-title":"Budd-Chiari Syndrome","volume":"44","author":"Coilly","year":"2020","journal-title":"Clin. Res. Hepatol. Gastroenterol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1007\/s00261-011-9779-9","article-title":"Cavernous Vessels around a Patent Portal Trunk in the Liver Hilum","volume":"37","author":"Qi","year":"2012","journal-title":"Abdom. Imaging"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1148\/radiol.2411051102","article-title":"Atrophy-Hypertrophy Complex in Patients with Cavernous Transformation of the Portal Vein: CT Evaluation","volume":"241","author":"Vilgrain","year":"2006","journal-title":"Radiology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.3748\/wjg.v18.i26.3375","article-title":"How Can Portal Vein Cavernous Transformation Cause Chronic Incomplete Biliary Obstruction?","volume":"18","author":"Harmanci","year":"2012","journal-title":"World J. Gastroenterol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/000992280003901209","article-title":"Cavernous Transformation of the Portal Vein: A Cause of Thrombocytopenia and Splenomegaly","volume":"39","author":"Klopfenstein","year":"2000","journal-title":"Clin. Pediatr. Phila."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jpedsurg.2008.02.005","article-title":"Subtotal Laparoscopic Splenectomy and Esophagogastric Devascularization for the Thrombocytopenia Because of Portal Cavernoma\u2014Case Report","volume":"43","author":"Vasilescu","year":"2008","journal-title":"J. Pediatr. Surg."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Wei, B., Huang, Z., and Tang, C. (2022). Optimal Treatment for Patients With Cavernous Transformation of the Portal Vein. Front. Med., 9.","DOI":"10.3389\/fmed.2022.853138"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.arcped.2007.07.009","article-title":"Hyperplasie nodulaire multifocale compliquant un cavernome porte","volume":"14","author":"Descottes","year":"2007","journal-title":"Arch. P\u00e9diatr."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2004.04.025","article-title":"Liver Nodules Ressembling Focal Nodular Hyperplasia after Portal Vein Thrombosis","volume":"41","author":"Bureau","year":"2004","journal-title":"J. Hepatol."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1007\/s00330-011-2161-z","article-title":"Focal Nodular Hyperplasia-like Lesions in Patients with Cavernous Transformation of the Portal Vein: Prevalence, MR Findings and Natural History","volume":"21","author":"Marin","year":"2011","journal-title":"Eur. Radiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s12664-013-0368-4","article-title":"Primary Extrahepatic Portal Vein Obstruction in Adults: A Single Center Experience","volume":"33","author":"Amarapurkar","year":"2014","journal-title":"Indian J. Gastroenterol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.1007\/s10620-023-07993-3","article-title":"Natural History and Outcomes of Cavernous Transformation of the Portal Vein in Cirrhosis","volume":"68","author":"Attanasi","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-Sinusoidal Vascular Disease: Proposal and Description of a Novel Entity","volume":"4","author":"Rautou","year":"2019","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-Sinusoidal Vascular Disorder","volume":"77","author":"Sempoux","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s12072-017-9823-0","article-title":"Pathology of Idiopathic Non-Cirrhotic Portal Hypertension","volume":"11","author":"Kage","year":"2017","journal-title":"Hepatol. Int."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Giuli, L., Pallozzi, M., Venturini, G., Gasbarrini, A., Ponziani, F.R., and Santopaolo, F. (2023). Molecular Mechanisms Underlying Vascular Liver Diseases: Focus on Thrombosis. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241612754"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1002\/hep.26904","article-title":"Idiopathic Portal Hypertension: Natural History and Long-Term Outcome","volume":"59","author":"Siramolpiwat","year":"2014","journal-title":"Hepatology"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1148\/radiol.12111785","article-title":"Obliterative Portal Venopathy: Findings at CT Imaging","volume":"263","author":"Glatard","year":"2012","journal-title":"Radiology"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3348\/kjr.2022.0668","article-title":"Porto-Sinusoidal Vascular Disease: A Concise Updated Summary of Epidemiology, Pathophysiology, Imaging, Clinical Features, and Treatments","volume":"24","author":"Jin","year":"2023","journal-title":"Korean J. Radiol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/j.1365-2036.2012.05112.x","article-title":"Idiopathic Noncirrhotic Portal Hypertension Is Associated with Poor Survival: Results of a Long-term Cohort Study","volume":"35","author":"Schouten","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2024.07.035","article-title":"Porto-Sinusoidal Vascular Liver Disorder with Portal Hypertension: Natural History and Long-Term Outcome","volume":"82","author":"Magaz","year":"2025","journal-title":"J. Hepatol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.cgh.2020.11.039","article-title":"Clinical Course of Porto-Sinusoidal Vascular Disease Is Distinct From Idiopathic Noncirrhotic Portal Hypertension","volume":"20","author":"Semmler","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00535-007-2025-0","article-title":"Hepatocellular Carcinoma Developing Six and a Half Years after a Diagnosis of Idiopathic Portal Hypertension","volume":"42","author":"Isobe","year":"2007","journal-title":"J. Gastroenterol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII\u2014Renewing Consensus in Portal Hypertension","volume":"76","author":"Bosch","year":"2022","journal-title":"J. Hepatol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","article-title":"Personalised Management of Patients with Hepatocellular Carcinoma: A Multiparametric Therapeutic Hierarchy Concept","volume":"24","author":"Vitale","year":"2023","journal-title":"Lancet Oncol."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Liu, F.-Y., Wang, M.-Q., Duan, F., Fan, Q.-S., Song, P., and Wang, Y. (2013). Hepatocellular Carcinoma Associated with Budd-Chiari Syndrome: Imaging Features and Transcatheter Arterial Chemoembolization. BMC Gastroenterol., 13.","DOI":"10.1186\/1471-230X-13-105"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1056\/NEJMc1214222","article-title":"Hepatocellular Carcinoma after the Fontan Procedure","volume":"368","author":"Asrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"101065","DOI":"10.1016\/j.jhepr.2024.101065","article-title":"Atezolizumab\/Bevacizumab or Lenvatinib in Hepatocellular Carcinoma: Multicenter Real-World Study with Focus on Bleeding and Thromboembolic Events","volume":"6","author":"Jochheim","year":"2024","journal-title":"JHEP Rep."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"e7025","DOI":"10.1002\/cam4.7025","article-title":"Efficacy and Safety of Atezolizumab plus Bevacizumab in Patients with Portal Hypertension for Unresectable Hepatocellular Carcinoma","volume":"13","author":"Kinami","year":"2024","journal-title":"Cancer Med."},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Niimura, T., Goda, M., Miyata, K., Matsumoto, J., Yoshioka, T., Hamano, H., Aizawa, F., Yagi, K., Izawa-Ishizawa, Y., and Zamami, Y. (2023). Evaluation of Cardiovascular Toxicity of the Atezolizumab and Bevacizumab Combination. Front. Drug Saf. Regul., 3.","DOI":"10.3389\/fdsfr.2023.1213771"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1148\/radiology.202.2.9015047","article-title":"Blood Flow and Liver Imaging","volume":"202","author":"Itai","year":"1997","journal-title":"Radiology"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/264440a0","article-title":"Hyperplastic Nodules after Portacaval Anastomosis in Rats","volume":"264","author":"Weinbren","year":"1976","journal-title":"Nature"},{"key":"ref_102","first-page":"107","article-title":"Changes in the liver and brain after portacaval and modified portacaval end-to-side anastomosis: Histology, autoradiography and clinical studies","volume":"99","author":"Rasenack","year":"1981","journal-title":"Fortschr. Med."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1148\/radiol.09090738","article-title":"Hepatocellular Carcinoma Associated with Membranous Obstruction of the Inferior Vena Cava: Incidence, Characteristics, and Risk Factors and Clinical Efficacy of TACE","volume":"254","author":"Gwon","year":"2010","journal-title":"Radiology"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.jpedsurg.2008.11.003","article-title":"Liver Nodules after Portal Systemic Shunt Surgery for Extrahepatic Portal Vein Obstruction in Children","volume":"44","author":"Porras","year":"2009","journal-title":"J. Pediatr. Surg."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.humpath.2023.09.010","article-title":"Focal Nodular Hyperplasia\u2013like Nodules Arising in the Setting of Hepatic Vascular Disorders with Portosystemic Shunting Show \u03b2-Catenin Activation","volume":"142","author":"Umetsu","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/hep.32256","article-title":"Sphingosine-1-phosphate Promotes Tumor Development and Liver Fibrosis in Mouse Model of Congestive Hepatopathy","volume":"76","author":"Kawai","year":"2022","journal-title":"Hepatology"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Chen, T., Zhang, H., Shan, W., Zhou, J., and You, Y. (2025). Liver Sinusoidal Endothelial Cells in Hepatic Fibrosis: Opportunities for Future Strategies. Biochem. Biophys. Res. Commun., 766.","DOI":"10.1016\/j.bbrc.2025.151881"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1053\/j.gastro.2011.12.017","article-title":"Role of Differentiation of Liver Sinusoidal Endothelial Cells in Progression and Regression of Hepatic Fibrosis in Rats","volume":"142","author":"Xie","year":"2012","journal-title":"Gastroenterology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jhep.2019.01.009","article-title":"Low Specificity of Washout to Diagnose Hepatocellular Carcinoma in Nodules Showing Arterial Hyperenhancement in Patients with Budd-Chiari Syndrome","volume":"70","author":"Purcell","year":"2019","journal-title":"J. Hepatol."}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2060\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:55:28Z","timestamp":1760032528000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/17\/13\/2060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":109,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["cancers17132060"],"URL":"https:\/\/doi.org\/10.3390\/cancers17132060","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}